Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer
- 18 January 2012
- journal article
- research article
- Published by Wiley in Journal of Surgical Oncology
- Vol. 106 (1) , 89-93
Abstract
Background: The axillary reverse mapping (ARM) technique has been proposed to prevent arm lymphedema. We conducted this study to assess the feasibility of the technique and the outcomes of patients with neoadjuvant chemotherapy (NAC).Methods: From July 2009 to May 2010, a prospective study was performed in 36 patients with breast cancer undergoing an ALND. The ARM technique was performed injecting 3 cm3 of Patent Blue in the ipsilateral arm. Of the 36 patients, 29 patients received NAC previously to the ARM and 7 patients had an ALND and ARM performed as first treatment for positive axillary nodes.Results: The identification rate of blue nodes was 83.3% (30 patients). Sentinel lymph node (SLN) was performed in 15 of 29 (42%) patients in the NAC group. Of these 15, two patients (13%) had a concordance between the blue and the hot node. Blue nodes were positive in 4 (13%) of the 30 patients.Conclusions: The ARM technique is feasible in patients undergoing NAC. Patients with extensive nodal involvement have increased risk of having positive blue nodes. More studies are needed to assess the subgroup of patients with positive axilla that may have the blue node spared without compromising the oncological treatment. J. Surg. Oncol. 2012; 106:89–93.Keywords
This publication has 26 references indexed in Scilit:
- Risk factors for lymphedema in breast cancer survivors, the Iowa Women’s Health StudyBreast Cancer Research and Treatment, 2011
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsCancer, 2010
- Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancerJournal of Surgical Oncology, 2010
- Extensive Nodal Disease May Impair Axillary Reverse Mapping in Patients With Breast CancerJournal of Clinical Oncology, 2009
- Intraoperative Assessment of Sentinel Lymph Nodes After Neoadjuvant Chemotherapy in Patients with Breast CancerAnnals of Surgical Oncology, 2009
- Risk factors for arm lymphedema following breast cancer diagnosis in Black women and White womenBreast Cancer Research and Treatment, 2008
- Lymphedema following axillary lymph node dissection for breast cancerSurgical Oncology, 2006
- Randomized Multicenter Trial of Sentinel Node Biopsy Versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC TrialJNCI: Journal of the National Cancer Institute, 2006
- Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast CancerArchives of Surgery, 2003
- Comparison of morbidity between axillary lymph node dissection and sentinel node biopsyEuropean Journal of Surgical Oncology, 2003